Analyst Reco. OptiNose, Inc.

Equities

OPTN

US68404V1008

Real-time Estimate Cboe BZX Other stock markets 09:33:07 2024-04-23 am EDT			5-day change	1st Jan Change
1.02 ^USD	-0.97%		-13.45%	-20.16%

Mar. 18	Lake Street Adjusts Price Target on OptiNose to $4 From $3, Maintains Buy Rating	MT
Mar. 18	Sector Update: Health Care Stocks Steady Premarket Monday	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lake Street Adjusts Price Target on OptiNose to $4 From $3, Maintains Buy Rating	Mar. 18	MT
HC Wainwright Initiates OptiNose With Buy Rating, $5 Price Target	Mar. 11	MT
Lake Street Initiates OptiNose at Buy Rating With $3 Price Target	23-08-21	MT
BMO Capital Adjusts Price Target on OptiNose to $5 From $6, Maintains Outperform Rating	22-11-14	MT
Jefferies Assumes OptiNose at Buy with $5 Price Target	22-10-21	MT
OPTINOSE : RBC Cuts Price Target on OptiNose to $10 From $17 on Lower Long-Term Sales Estimates; Outperform-Speculative Risk Rating Kept	21-05-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer